Sign inJoin waitlistJoin the waitlist

JA

Jay Andersen

Physician · The US Oncology Network

Credentials: · · · · ·

History

The US Oncology Network
Present

Medical Oncology
1999–2001
Internal Medicine
1996–1999
Univ of Kansas Sch of Med
1992–1996

Research

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2022 · 1,014 citations
FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Annals of Oncology · 2019 · 122 citations
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer
Clinical Cancer Research · 2022 · 50 citations

MD
Michael Danso
4 papers
JB
Joanne Blum
3 papers
AF
Anne Favret
2 papers
CO
Cynthia Osborne
2 papers
DP
Debra Patt
2 papers
Heather McArthur
2 papers
JB
J Beck
2 papers
Jennifer Litton
2 papers
Lida Mina
2 papers
Melinda Telli
2 papers
RB
Raymond Brig
2 papers
SI
Steven Isakoff
2 papers

Clinical trials

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2024–2030
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Site PI · Recruiting · Phase 3
Greenwich LifeSciences, Inc.
2022–2031